Healthcare

I challenge you to find any value in this coverage of LabCorp.
They remind me of the old-line pharma companies in their formative years.
These healthcare stocks may not be in ‘hot’ sectors, but they are outpacing the market nonetheless.
Becton Dickinson’s P/E ratio is far below the 10-year median, and its payout has become quite generous.
At least three Fibonacci time cycles support a bullish stance against this recent low.
You have to like a stock that goes higher on disappointment.
As M&A action heats up in the sector, consider two names that could shape up to be prime targets.
Even given the sharp climb in these stocks, they likely still have room to run.
Under the surface, I'm not seeing the sort of frenzied buying that the numbers suggest.
If the healthcare plan stands, these names stand to reap rich rewards.

Columnist Conversation / Market Updates

| May 24, 2013
| 3:24 PM EDT
There is no technical damage on the daily chart of $SPX at this point. Actually this decline is only similar to prior d...
| May 24, 2013
| 3:17 PM EDT
Metlife Inc. became very overbought last week reaching a level not seen in over a year. MET had been in rally mode...

Our Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.